The ICP - Innovators Commercialisation Program is led by Asia Research & Innovation Alliance (ARIA)'s Institute of Healthtech Excellence, in collaboration with the National University Hospital of Singapore (NUHS) - Centre for Innovation in Healthcare (CIH). ICP program helps innovators to accelerate their product validation and expansion into Singapore.
A global team of healthcare professionals and clinicians will offer clinical validation and venture building support to grow your business in Singapore and the region over a 6 months program. Completion of the ICP program will allow innovators access to venture investment of up to USD1,000,000.
BENEFITS OF THE PROGRAM
- Venture Funding of $1million Dollars
- Establish Global HQ in Singapore with Regulatory Incentives
- Fast Track to Clinical Adoption and Trials in Singapore and across Asia
- Network with the largest Medtech companies in the world
- Access to a Global Committee of Medical Industry Professionals
PROGRAM THEMES
1. Improving Users Lifespans and Quality of Life
2. Enabling Seamless Delivery of High-Quality Healthcare
3. Digitalisation of Hospital Systems
4. Enhancing Women's and Children's Health Outcomes
PROGRAM STRUCTURE
The program is split into 3 phases of 6 months in total:
1. Phase 1 covers the Clinical Validation phase with the NUHS-CIH team, with access to 3 major hospitals and 8 polyclinics in Singapore.
2. Phase 2 is the product actuation process with the venture building team comprising of top medical industry professionals.
3. Phase 3 is the venture funding and scale-up process, with key support provided in operational roles
SELECTION CRITERIA
1. Prototypes have been developed
2. Patents approved or pending approval
3. Obtained preliminary clinical trial data and/or published in research publications
4. Business plans developed
HOW DO YOU APPLY?
Send your 1 slide business plan to connect@ariainstitute.org OR apply through the website https://www.ariainstitute.org/icp
Company Details
- Employees
- 2
- Address
- Singapore, Sg
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Keywords
- CISTEC AG.
- HQ
- Singapore
Icp | Innovators Commercialisation Program Questions
Icp | Innovators Commercialisation Program's website is https://www.ariainstitute.org/icp
Icp | Innovators Commercialisation Program's LinkedIn profile is https://sg.linkedin.com/company/icp-innovators-commercialisation-program
Icp | Innovators Commercialisation Program has
2 employees.
View email and phone details for 2
employees at Icp | Innovators Commercialisation Program.
Icp | Innovators Commercialisation Program's industry is
Medical Equipment Manufacturing
Icp | Innovators Commercialisation Program's top competitors are
Suzhou Faigle Engineering Plastics Co., Ltd.,
Dvla Offices,
22health Ventures,
Women Inspired World,
Pacificbridge Capital Llc,
Cistec Ag,
Fathomx,
Phoenixus,
Deepblue Technology Official,
Centre For Medtech & Innovations (Cmti).
Icp | Innovators Commercialisation Program's categories are Medical Equipment Manufacturing
